Is it bronchiolitis obliterans syndrome or is it chronic rejection: A reappraisal?

European Respiratory Journal

Volumn 25, Issue 2, 2005, Pages 221-224

  Verleden, Geert M ^a   Dupont, L J ^a   Van Raemdonck, D E ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bronchiolitis obliterans syndrome; Chronic rejection; Lung transplantation

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLOSPORIN; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; CHRONIC GRAFT REJECTION; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DETERIORATION; DISEASE SEVERITY; DRUG MECHANISM; DRUG MEGADOSE; DRUG RESPONSE; EISENMENGER COMPLEX; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEART LUNG TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH FUNDOPLICATION; TRANSBRONCHIAL BIOPSY;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIOLITIS OBLITERANS; CHRONIC DISEASE; GASTROESOPHAGEAL REFLUX; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SYNDROME;

EID: 13844254905     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.05.00057404     Document Type: Review

References (30)

1. Trulock EP, Edwards LB, Taylor DO, et al. The registry of the International Society for Heart and Lung Transplantation: twentieth official adult heart-lung report - 2003. J Heart Lung Transplant 2003; 22: 625-635.
2. Reichenspurner H, Girgis RE, Robbins BC, et al. Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation. Ann Thorac Surg 1996; 62: 1467-1472.
3. Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Surg 1999; 230: 362-370.
4. Whitehead B, Rees P, Sorensen K, et al. Incidence of obliterative bronchiolitis after heart-lung transplantation in children. J Heart Lung Transplant 1993; 12: 903-908.
5. Ouwens JP, van der Mark TW, Koëter GH, de Boer WJ, Grevink RG, van der Bij W. Bronchiolar airflow impairment after lung transplantation: an early and common manifestation. J Heart Lung Transplant 2002; 21: 1056-1061.
6. Van Raemdonck D, Verleden G, Vanhaecke J, et al. The current status of lung transplantation. Acta Chir Austriaca 1999, 31: 292-301.
7. Tamm M, Sharples L, Higenbottam T, Steward S, Wallwork J. Bronchiolitis obliterans syndrome (BOS) following heart-lung transplantation. Transpl Int 1996; 9: Suppl. 1, S299-S302.
8. Glanville AR, Baldwin JC, Burke CM, Theodore J, Robin ED. Obliterative bronchiolitis after heart-lung transplantation: apparent arrest by augmented immunosuppression. Ann Int Med 1987; 107: 300-304.
9. Verleden GM. Bronchiolitis obliterans syndrome after lung transplantation: medical treatment. Monaldi Arch Chest Dis 2000; 55: 140-145.
10. Stewart S. The pathology of lung transplantation. Sem Diagnostic Pathol 1992; 9: 210-219.
11. Pomerance A, Madden B, Burke MM, Yacoub MH. Transbronchial biopsy in heart and lung transplantation: clinicopathologic correlations. J Heart Lung Transplant 1995; 14: 761-763.
12. Kramer MR, Stoehr C, Wang JL, et al. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial biopsies. J Heart Lung Transplant 1993; 12: 675-681.
13. Cooper JD, Billingham M, Egan T, et al. A working formulation for the standardisation of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 1993; 12: 713-716.
14. Estenne M, Maurer J, Boehler A, et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002; 21: 297-310.
15. Patterson GM, Wilson S, Whang JL, et al. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second. J Heart Lung Transplant 1996; 15: 175-181.
16. Reynaud-Gaubert M, Thomas P, Badier M, Cau P, Giudicelli R, Fuentes P. Early detection of airway involvement in obliterative bronchiolitis after lung transplantation. Functional and bronchoalveolar lavage findings. Am J Respirt Crit Care Med 2000; 161: 1924-1929.
17. Palmer SM, Miralles AP, Howell DN, Brazer SR, Tapson VF, Davis RD. Gastroesophageal reflux as a reversible cause of allograft dysfunction after lung transplantation. Chest 2000; 118: 1214-1217.
18. Young LR, Hadjiliadis D, Davis D, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest 2003; 124: 1689-1693.
19. Hadjiliadis D, Davis RD, Steele MP, et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003; 17: 363-368.
20. Davis D, Lau CL, Eubanks SS, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg 2003; 125: 533-542.
21. Maes BD, Vanwalleghem J, Kuypers D, Ghoos Y, Rutgeerts P, Vanrenterghem Y, Differences in gastric motor activity in renal transplant patients treated with FK-506 versus ciclosporine. Transplantation 1999; 68: 1482-1485.
22. Verleden GM, Besse T, Maes B. Successfull conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. Transplantation 2002; 73: 1974-1976.
23. Schachter LM, Dixon J, Pierce RJ, O'Brien P. Severe gastroesophageal reflux is associated with reduced carbon monoxide diffusing capacity. Chest 2003; 123: 1932-1938.
24. Stanbrook MB, Kesten S. Bronchial hyperreactivity after lung transplantation predicts eary bronchiolitis obliterans. Am J Respir Crit Care Med 1999; 160: 2034-2039.
25. Hartwig MG, Cantu E, Appel JZ, Woreta H, Palmer SH, Davis RD. Non-alloimmune injury mediated by gastroesophageal reflux precipitates alloimmune injury in lung transplant patients. J Heart Lung Transplant 2004; 23: Suppl. 1, S43.
26. Gerhardt S, McDyer JF, Girgis RE, Conte JV, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome. Am J Respir Crit Care med 2003; 168: 121-125.
27. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004; 77: 1465-1467.
28. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002; 166: 440-444.
29. Ward C, Camara M, Forrest I, et al. Preliminary findings of quorum signal molecules in clinically stable lung allograft recipients. Thorax 2003; 58: 444-446.
30. DiGiovine B, Lynch JP 3rd, Martinez FJ, et al. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation. J Immunol 1996; 157: 4194-4202.